NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- Failed Trial Suggests Circulating Tumor DNA Monitoring Not as Universally Applicable as Hoped
- Revvity Launches NGS Panel, Workflow to Complement Current Newborn Screening
- Investors React to Initial Data on Freenome's Blood-Based Colon Cancer Detection Test
- Rare Genetic Contributors to Left-Handedness Uncovered Using UK Biobank Exomes
- Natera Stock Spikes on Results From Bladder Cancer Phase III Surveillance Trial